Home>Topics>Stocks>Arena Pharmaceuticals

Arena Pharmaceuticals ARNA

  1. All
  2. Commentary
  3. Headlines
    1. From Barron’s, March 3, 2014 (Part 1)

      Commentary

      Sat, 1 Mar 2014

      may result in market up by high-single-digits in 2014. Weight-loss stocks [ WTW, NTRI ] and diet-drug stocks [ VYUS, ARNA ] have been hit with company specific issues [ the obesity problem hasn’t gone away after all ] but they may not have bottomed

    2. Global Equities: What’s Up With Emerging Markets?

      Headlines

      Tue, 10 Dec 2013

      Arena Pharmaceuticals ' future depends on its late-stage obesity drug.

    3. European health regulator raises concerns over Arena obesity drug

      Headlines

      Tue, 22 Jan 2013

      Jan 22 (Reuters) - Arena Pharmaceuticals Inc said the European health regulator had raised concerns with the company's obesity drug, Belviq, sending its shares down as much as 10 percent.

    4. The Best Small Cap Performers of 2012

      Headlines

      Fri, 28 Dec 2012

      appearing to rebound, it’s little wonder that Ellie Mae has found strong demand for its product. Arena Pharma (NASDAQ: ARNA ): is up roughly 367 percent in 2012. It’s been overshadowed in the biotech world by Sarepta, but more than tripling in a single

    5. Vivus, Arena shares jump on insurance coverage for diet pills

      Headlines

      Wed, 21 Nov 2012

      (Reuters) - Health insurer Aetna Inc said it would provide coverage for diet pills of Vivus Inc and Arena Pharmaceuticals Inc , sending the obesity drugmakers' shares up.

    6. Vivus, Arena shares jump on insurance coverage for diet pills

      Headlines

      Wed, 21 Nov 2012

      (Reuters) - Health insurer Aetna Inc said it would provide coverage for Vivus Inc's and Arena Pharmaceuticals Inc's diet pills, sending the obesity drugmakers's shares up.

    7. Opportunity Now: Reasons For Small/Microcap Company Optimism

      Headlines

      Fri, 21 Sep 2012

      Opportunities Fund nor the Perritt Ultra MicroCap fund held a position in Pharmacyclics Inc. (PCYC), Arena Pharmaceuticals , Inc. ( ARNA ), Home Depot (HD) or Inhibitex, Inc. (INHX). The Perritt MicroCap Opportunities Fund held a 1

    8. FDA OKs first obesity drug in 13 years

      Headlines

      Wed, 27 Jun 2012

      NEW YORK/WASHINGTON (Reuters) - U.S. health regulators approved the first new weight-loss drug in 13 years, allowing Arena Pharmaceuticals Inc to bring its Belviq pill to market as public health...

    9. Arena shares slump 14 pct before diet drug ruling

      Headlines

      Fri, 22 Jun 2012

      (Reuters) - Shares of Arena Pharmaceuticals Inc fell 15 percent on Friday, days ahead of a key meeting at which U.S. regulators will rule on whether to approve its experimental weight-loss drug.

    10. Arena shares soar as experts recommend approval for obesity drug

      Headlines

      Fri, 11 May 2012

      (Reuters) - Shares of Arena Pharmaceuticals Inc nearly doubled in value after a panel of experts recommended approval of the company's obesity pill, a big step towards making it the first new diet...

    « Prev1234Next »
    Content Partners